Compare ADMA Biologics Inc (ADMA) vs RLX Technology Inc (RLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs RLX Technology Inc — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while RLX Technology Inc trades at $1.98 (market cap $2.42B). The key difference: ADMA Biologics Inc and RLX Technology Inc are close in size by market cap, and RLX Technology Inc pays a 5.05% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | RLX | |
|---|---|---|
Market Cap | $2.22B | $2.42B |
Sector | Health | Technology |
52-Week High | $20.38 | $2.73 |
52-Week Low | $7.60 | $1.79 |
Enterprise Value | $2.29B | $1.04B |
Dividend Yield | — | 5.05% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →
